Matches in Wikidata for { <http://www.wikidata.org/entity/Q83877766> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q83877766 description "artículu científicu espublizáu en xunu de 2006" @default.
- Q83877766 description "bài báo khoa học" @default.
- Q83877766 description "scientific article published on 01 June 2006" @default.
- Q83877766 description "wetenschappelijk artikel" @default.
- Q83877766 description "наукова стаття, опублікована в червні 2006" @default.
- Q83877766 name "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 name "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 type Item @default.
- Q83877766 label "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 label "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 prefLabel "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 prefLabel "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 P1433 Q83877766-3EBF8817-41F7-493E-8173-60F33A96D352 @default.
- Q83877766 P1476 Q83877766-2EE29E96-6A61-4FA3-A03F-63675B849621 @default.
- Q83877766 P2093 Q83877766-19CA1151-15DF-49C4-8D6B-B2502DB03383 @default.
- Q83877766 P2093 Q83877766-EE57BA54-512C-4379-9028-71D1E91D387C @default.
- Q83877766 P304 Q83877766-C1CACC00-8048-41FD-A7AC-403B787161D0 @default.
- Q83877766 P31 Q83877766-F2B6563F-4AEB-48E4-870C-1B8BBD29122E @default.
- Q83877766 P356 Q83877766-B6300636-81F5-4EAE-B416-2BC316CB6437 @default.
- Q83877766 P433 Q83877766-A50FBCA3-50CD-4508-B0AA-B5639119F76F @default.
- Q83877766 P478 Q83877766-3CE91C4A-AFD1-498E-8B9A-71E3AE701DCF @default.
- Q83877766 P577 Q83877766-20BFB5CD-B49C-4756-8CFF-1776E9C8C67C @default.
- Q83877766 P698 Q83877766-EAB4F575-86B8-4922-A7C9-A2805E23ACB7 @default.
- Q83877766 P921 Q83877766-0AF2CC17-4D53-4A26-BAB8-5AD06B5AC946 @default.
- Q83877766 P921 Q83877766-73EF2B1C-9A6C-423D-976B-8CEA09EDCD1D @default.
- Q83877766 P356 JCO.2006.05.6184 @default.
- Q83877766 P698 16735718 @default.
- Q83877766 P1433 Q400292 @default.
- Q83877766 P1476 "Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?" @default.
- Q83877766 P2093 "Lawrence H Einhorn" @default.
- Q83877766 P2093 "Richard S Foster" @default.
- Q83877766 P304 "2597-8; author reply 2598-9" @default.
- Q83877766 P31 Q13442814 @default.
- Q83877766 P356 "10.1200/JCO.2006.05.6184" @default.
- Q83877766 P433 "16" @default.
- Q83877766 P478 "24" @default.
- Q83877766 P577 "2006-06-01T00:00:00Z" @default.
- Q83877766 P698 "16735718" @default.
- Q83877766 P921 Q412415 @default.
- Q83877766 P921 Q418817 @default.